Dr. Ottavio Arancio

• 
  www.CaregiversHomeCT.com/news/article.cfm?UID=2288 - [Cached Version]
  Published on: 10/6/2009    Last Visited: 10/12/2009  

  "People often joke that they must have Alzheimer's because they can't remember where they put their keys, but for a person with the disease, this type of short-term memory loss is extremely debilitating," said the study's lead author, Ottavio Arancio, PhD, associate professor at the Taub Institute for Research on Alzheimer's Disease and the Aging Brain at Columbia University Medical Center in New York.
  
  Arancio said the Alzheimer's benefit was uncovered by using the cancer drug to targets a previously unknown defect in the brains of mice with Alzheimer's.
  
  He said it appears the memory improves with HDAC inhibitors because they affect the way the brain records new memories.

• 
  www.crh.org/body_layout.cfm?id=6&action=detail&aeproduc - [Cached Version]
  Published on: 9/3/2009    Last Visited: 9/11/2009  

  "People often joke that they must have Alzheimer's because they can't remember where they put their keys, but for a person with the disease, this type of short-term memory loss is extremely debilitating," study author Ottavio Arancio, an associate professor of pathology and cell biology at Columbia University Medical Center, said in a news release.

• 
  www.eurekalert.org/pub_releases/2008-07/joci-cin062708. - [Cached Version]
  Published on: 6/27/2008    Last Visited: 7/2/2008  

  Ottavio Arancio and colleagues, at Columbia University, New York, have now shown that two different drugs that inhibit calpains can improve memory in a mouse model of Alzheimer disease (APP/PS1 mice), leading them to suggest drugs that target calpains might stop or slow down the memory loss that occurs as Alzheimer disease progresses.
  ...
  Ottavio Arancio Columbia University, New York, New York, USA. Phone: (212) 851-4617; Fax: (212) 851-4602; E-mail: oa1@columbia.edu.
  
  View the PDF of this article at: https://www.the-jci.org/article.php?id=34254

• 
  www.naturalmedicine.com/news_agingwell.php?subaction=sh - [Cached Version]
  Published on: 3/1/2008    Last Visited: 3/1/2008  

  explained Ottavio Arancio, M.D., Ph.D., Assistant Professor of Pathology at Columbia University Medical Center and co-principal investigator of the study with Michael Shelanski, MD, Ph.D., Chairman of the Department of Pathology at the Columbia University College of Physicians and Surgeons.

• 
  biz.yahoo.com/bw/070605/20070605005258.html?.v=1 - [Cached Version]
  Published on: 7/6/2005    Last Visited: 6/10/2007  

  Joining Dr. Weaver in conducting the work are two primary co-investigators Ottavio Arancio, M.D., Ph.D., of Columbia University Medical Center in New York City and Edwin De Pauw, Ph.D., of the Mass Spectrometry Laboratory at the Universite de Liege in Belgium.

• 
  www.genomeweb.com/biotechtransferweek/biofusion-univers - [Cached Version]
  Last Visited: 1/20/2009  

  Oligomerix will work in collaboration with Ottavio Arancio of the Columbia University Medical Center and Donald Weaver of Dalhousie University, both of whom are co-principal investigators on the program.

• 
  www.eurekalert.org/pub_releases/2008-07/joci-joe062708. - [Cached Version]
  Published on: 7/1/2008    Last Visited: 7/2/2008  

  Ottavio Arancio and colleagues, at Columbia University, New York, have now shown that two different drugs that inhibit calpains can improve memory in a mouse model of Alzheimer disease (APP/PS1 mice), leading them to suggest drugs that target calpains might stop or slow down the memory loss that occurs as Alzheimer disease progresses.
  ...
  Ottavio Arancio Columbia University, New York, New York, USA. Phone: (212) 851-4617; Fax: (212) 851-4602; E-mail: oa1@columbia.edu.
  
  View the PDF of this article at: https://www.the-jci.org/article.php?id=34254

• 
  9th International Conference on Alzheimer’s Disease... - [Cached Version]
  Published on: 7/2/2008    Last Visited: 9/12/2009  

  Ottavio Arancio, MD, PhD, Columbia University
  
  Dr. Ottavio Arancio received his Ph.D and M.D. from the University of Pisa (Italy). From 1981 to 1986 he took residency training in Neurology at the University of Verona (Italy). Dr. Arancio has held Faculty appointments at Columbia University, NYU School of Medicine and at SUNY HSCB. In 2004 he became Faculty member of the Dept of Pathology and Taub Institute for Research on Alzheimer's Disease and the Aging Brain at Columbia University. His honors include the "G. Moruzzi Fellowship" (Georgetown University), the "Anna Villa Rusconi Foundation Prize" (Italy), and the "INSERM Poste vert Fellowship" (France), Fidia Fellowship, Italy; Speaker's Fund for Biomedical Research Award; Investigator Initiated Research Award from the Alzheimer Association; AHAF centennial Award, Zenith Award, and Margaret Cahn Research Award (2008).
  
  Dr Arancio is a cellular neurobiologist who has contributed to the characterization of the mechanisms of learning in both normal conditions and during neurodegenerative diseases. During the last ten years he has pioneered the field of mechanisms of synaptic dysfunction in Alzheimer's disease. Dr. Arancio's laboratory has focused primarily on events triggered by amyloid protein.

• 
  9th International Conference on Alzheimer’s Disease... - [Cached Version]
  Published on: 10/7/2008    Last Visited: 9/12/2009  

  Plenary Talk: Neurobiology of Memory and Learning: Implications for Alzheimer's Disease and Cognitive Aging - Ottavio Arancio, MD, PhD, Columbia University

• 
  ADDF: Press Releases - [Cached Version]
  Published on: 7/7/2008    Last Visited: 6/25/2009  

  The work will be done in collaboration with Dr. Ottavio Arancio, MD, PhD (Columbia University Medical Center) and Dr. Donald Weaver, MD, PhD (Dalhousie University), both of whom are co-principal investigators.

Page:  1 2 3